Association Between Pediatric Clinical Trials and Global Burden of Disease

BACKGROUND: The allocation of research resources should favor conditions responsible for the greatest disease burden. This is particularly important in pediatric populations, which have been underrepresented in clinical research. Our aim was to measure the association between the focus of pediatric clinical trials and burden of disease and to identify neglected clinical domains. METHODS: We performed a cross-sectional study of clinical trials by using trial records in ClinicalTrials.gov. All trials started in 2006 or after and studying patient-level interventions in pediatric populations were included. Age-specific measures of disease burden were obtained for 21 separate conditions for high-, middle-, and low-income countries. We measured the correlation between number of pediatric clinical trials and disease burden for each condition. RESULTS: Neuropsychiatric conditions and infectious diseases were the most studied conditions globally in terms of number of trials (874 and 847 trials, respectively), while intentional injuries (5 trials) and maternal conditions (4 trials) were the least studied. Clinical trials were only moderately correlated with global disease burden (r = 0.58, P = .006). Correlations were also moderate within each of the country income levels, but lowest in low-income countries (r = .47, P = .03). Globally, the conditions most understudied relative to disease burden were injuries (–260 trials for unintentional injuries and –160 trials for intentional injuries), nutritional deficiencies (–175 trials), and respiratory infections (–171 trials). CONCLUSIONS: Pediatric clinical trial activity is only moderately associated with pediatric burden of disease, and least associated in low-income countries. The mismatch between clinical trials and disease burden identifies key clinical areas for focus and investment.

[1]  John P A Ioannidis,et al.  Number of published systematic reviews and global burden of disease: database analysis , 2003, BMJ : British Medical Journal.

[2]  M. Mckee,et al.  Where There Is No Health Research: What Can Be Done to Fill the Global Gaps in Health Research? , 2012, PLoS medicine.

[3]  E. Cohen,et al.  An absence of pediatric randomized controlled trials in general medical journals, 1985-2004. , 2007, Journal of clinical epidemiology.

[4]  P. Ravaud,et al.  Lack of head-to-head trials and fair control arms: randomized controlled trials of biologic treatment for rheumatoid arthritis. , 2012, Archives of internal medicine.

[5]  C. Murray,et al.  Global burden of disease , 1997, The Lancet.

[6]  Richard M. Smith,et al.  Global health priorities and research funding. , 2013, The Lancet. Infectious diseases.

[7]  F. Catalá-López,et al.  Does the development of new medicinal products in the European Union address global and regional health concerns? , 2010, Population health metrics.

[8]  J. Ioannidis,et al.  Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment , 2013, BMJ : British Medical Journal.

[9]  D. Redelmeier,et al.  Modern Medicine Is Neglecting Road Traffic Crashes , 2013, PLoS medicine.

[10]  P. Kolsteren,et al.  Diet and Physical Activity for the Prevention of Noncommunicable Diseases in Low- and Middle-Income Countries: A Systematic Policy Review , 2013, PLoS medicine.

[11]  P. Garner,et al.  Integrating Global and National Knowledge to Select Medicines for Children: The Ghana National Drugs Programme , 2013, PLoS medicine.

[12]  M. Weyden.  The International Committee of Medical Journal Editors , 2006 .

[13]  B. Vandermeer,et al.  Controlled Trials in Children: Quantity, Methodological Quality and Descriptive Characteristics of Pediatric Controlled Trials Published 1948-2006 , 2010, PloS one.

[14]  D. Warrell,et al.  Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial , 2008, The Lancet.

[15]  Roderik F. Viergever,et al.  The Quality of Registration of Clinical Trials , 2011, PloS one.

[16]  John P A Ioannidis,et al.  Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research , 2002, BMJ : British Medical Journal.

[17]  John Hoey,et al.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2005, Circulation.

[18]  John P A Ioannidis,et al.  Neglected tropical diseases: survey and geometry of randomised evidence , 2012, BMJ : British Medical Journal.

[19]  H. Bauchner,et al.  Child Versus Adult Research: The Gap in High-Quality Study Design , 2008, Pediatrics.

[20]  C. McCulloch,et al.  NIH Disease Funding Levels and Burden of Disease , 2011, PloS one.

[21]  J. PérezMartín,et al.  [International Committee of Medical Journal Editors]. , 2008, Revista alergia Mexico.

[22]  Florence T. Bourgeois,et al.  Pediatric Versus Adult Drug Trials for Conditions With High Pediatric Disease Burden , 2012, Pediatrics.

[23]  R. Goldman,et al.  Child vs adult randomized controlled trials in specialist journals: a citation analysis of trends, 1985-2005. , 2010, Archives of pediatrics & adolescent medicine.

[24]  N. Powe,et al.  The relation between funding by the National Institutes of Health and the burden of disease. , 1999, The New England journal of medicine.

[25]  Nicholas C. Ide,et al.  The ClinicalTrials.gov results database--update and key issues. , 2011, The New England journal of medicine.

[26]  L. Smeeth,et al.  Tackling Non-Communicable Diseases In Low- and Middle-Income Countries: Is the Evidence from High-Income Countries All We Need? , 2013, PLoS medicine.